Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model
Group A Streptococcus (GAS) is a major human pathogen for which there is no licensed vaccine. To protect against infection, a strong systemic and mucosal immune response is likely to be necessary to prevent initial colonization and any events that might lead to invasive disease. A broad immune respo...
Main Authors: | Helen Alexandra Shaw, Alex Remmington, Giselle McKenzie, Caroline Winkel, Fatme Mawas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/11/1724 |
Similar Items
-
A Review of <i>Streptococcus pyogenes</i>: Public Health Risk Factors, Prevention and Control
by: Nelly Janira Avire, et al.
Published: (2021-02-01) -
Multicomponent Vaccines against Group A Streptococcus Can Effectively Target Broad Disease Presentations
by: Helen A. Shaw, et al.
Published: (2021-09-01) -
Increasing Incidence of Invasive Group A Streptococcus Disease, Idaho, USA, 2008–2019
by: Eileen M. Dunne, et al.
Published: (2022-09-01) -
Spontaneous Streptococcus pyogenes pelvic inflammatory disease; Case report and review of the literature
by: A Snyder, et al.
Published: (2020-01-01) -
Are clinicians overdiagnosing strep throat and overprescribing antibiotics?
by: Kennedy A. Sabharwal, et al.
Published: (2023-11-01)